Sven Norbert Reske
#160,844
Most Influential Person Now
Sven Norbert Reske's AcademicInfluence.com Rankings
Sven Norbert Reskeengineering Degrees
Engineering
#6919
World Rank
#8274
Historical Rank
Biomedical Engineering
#653
World Rank
#663
Historical Rank

Sven Norbert Reskephilosophy Degrees
Philosophy
#9269
World Rank
#12803
Historical Rank
Logic
#6253
World Rank
#7754
Historical Rank

Download Badge
Engineering Philosophy
Sven Norbert Reske's Degrees
- Doctorate Medicine Stanford University
Why Is Sven Norbert Reske Influential?
(Suggest an Edit or Addition)Sven Norbert Reske's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. (2007) (1335)
- Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study (2003) (828)
- Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. (2003) (423)
- Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. (2005) (369)
- Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. (1999) (352)
- Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. (1997) (320)
- Extranodal malignant lymphoma: detection with FDG PET versus CT. (1998) (320)
- FDG-PET for clinical use (2001) (317)
- Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. (2001) (291)
- 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. (1998) (290)
- FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters (2002) (280)
- Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma” (2013) (275)
- Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. (1999) (275)
- Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures (2001) (243)
- Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease. (1998) (241)
- 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. (2002) (238)
- 2‐(fluorine‐18)fluoro‐2‐deoxy‐D‐glucose positron emission tomography in the detection and staging of malignant lymphoma (2001) (236)
- Experience with carbon-11 choline positron emission tomography in prostate carcinoma (2000) (227)
- Imaging prostate cancer with 11C-choline PET/CT. (2006) (222)
- Gene silencing by adenovirus‐delivered siRNA (2003) (219)
- Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. (1998) (217)
- FDG PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies. (1998) (212)
- Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. (1998) (212)
- The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. (2011) (210)
- Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. (1999) (208)
- Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. (2001) (206)
- New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. (2016) (202)
- Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. (2007) (200)
- Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. (2002) (199)
- FTDP‐17: An early‐onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation (1999) (190)
- Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography. (1995) (186)
- Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD (2005) (184)
- 131I/123I-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging (2003) (182)
- 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease. (2003) (181)
- Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. (2000) (180)
- Initial results in the assessment of multiple myeloma using 18F-FDG PET (2002) (180)
- FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. (1999) (174)
- Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma. (1997) (172)
- Values and Limitations of 18F-Fluorodeoxyglucose–Positron-Emission Tomography with Preoperative Evaluation of Patients with Pancreatic Masses (2000) (172)
- Molecular imaging of proliferation in malignant lymphoma. (2006) (169)
- Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT (2009) (169)
- [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy (2007) (168)
- Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer (2002) (165)
- 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. (1995) (164)
- Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. (2001) (160)
- Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer (2003) (159)
- Detection of liver metastases from pancreatic cancer using FDG PET. (1999) (154)
- Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). (1997) (153)
- FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. (2001) (151)
- Structured treatment interruption in patients with alveolar echinococcosis (2004) (149)
- Evaluation of [11C]‐choline positron‐emission/computed tomography in patients with increasing prostate‐specific antigen levels after primary treatment for prostate cancer (2007) (140)
- Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. (2000) (138)
- In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke (2000) (138)
- Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer. (2012) (120)
- Is 18F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? (2000) (119)
- Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2 (2010) (111)
- Dissociating a Common Working Memory Network from Different Neural Substrates of Phonological and Spatial Stimulus Processing (2002) (111)
- Positron emission tomography (PET) for staging of solitary plasmacytoma. (2003) (110)
- Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? (1999) (109)
- Biological characterisation of breast cancer by means of PET (2004) (109)
- Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? (2001) (101)
- Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience. (2007) (101)
- 131I/123I-Metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging (2003) (99)
- Clinical relevance of imaging proliferative activity in lung nodules (2005) (94)
- Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. (1999) (93)
- FDG-PET: procedure guidelines for tumour imaging (2003) (93)
- [Positron emission tomography in diagnosis of renal cell carcinoma]. (1996) (90)
- Positron emission tomography with 18-fluorodeoxyglucose in the staging and follow-up of lymphoma in the chest. (1999) (90)
- [11C]Choline PET/CT for Targeted Salvage Lymph Node Dissection in Patients with Biochemical Recurrence after Primary Curative Therapy for Prostate Cancer (2008) (83)
- Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma (1999) (83)
- Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells. (2007) (83)
- 188Re or 90Y‐labelled anti‐CD66 antibody as part of a dose‐reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I–II study (2005) (81)
- Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) in pancreatic cancer cell lines (2002) (80)
- RADIOIMMUNOIMAGING FOR DIAGNOSIS OF BONE MARROW INVOLVEMENT IN BREAST CANCER AND MALIGNANT LYMPHOMA (1989) (79)
- Is a preoperative multidiagnostic approach to predict surgical resectability of periampullary tumors still effective? (2001) (78)
- Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. (2010) (76)
- Breast scintigraphy: procedure guidelines for tumour imaging (2003) (74)
- Intracoronary β-Irradiation With a Liquid 188Re-Filled Balloon Six-Month Results From a Clinical Safety and Feasibility Study (2000) (74)
- Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: A 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study (2008) (71)
- Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours (2006) (71)
- Imaging Bone and Soft Tissue Tumors with the Proliferation Marker [18F]Fluorodeoxythymidine (2008) (68)
- Bone scintigraphy: procedure guidelines for tumour imaging (2003) (68)
- Cranial Neuronavigation with Direct Integration of 11C Methionine Positron Emission Tomography (PET) Data – Results of a Pilot Study in 32 Surgical Cases (2002) (67)
- Cost-Effectiveness of Hybrid PET/CT for Staging of Non–Small Cell Lung Cancer (2010) (66)
- PET and restaging of malignant lymphoma including residual masses and relapse (2003) (64)
- Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT (2007) (64)
- [11C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy (2009) (63)
- First Demonstration of Leukemia Imaging with the Proliferation Marker 18F-Fluorodeoxythymidine (2008) (62)
- 15(p-[123I]Iodophenyl)pentadecanoic acid as tracer of lipid metabolism: comparison with [1-14C]palmitic acid in murine tissues. (1984) (62)
- Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET. (2014) (62)
- Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma (2010) (59)
- PTEN mutation: many birds with one stone in tumorigenesis. (2008) (59)
- Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography. (2001) (57)
- 11C‐Choline positron‐emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer (2007) (56)
- S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version (2013) (55)
- Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia (1999) (54)
- Value of PET/CT and MR lymphography in treatment of prostate cancer patients with lymph node metastases. (2012) (53)
- Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? (2002) (52)
- [11C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy (2008) (51)
- Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography (2000) (51)
- Delusional infestation: Neural correlates and antipsychotic therapy investigated by multimodal neuroimaging (2010) (50)
- Imaging of activated microglia with PET and [11C]PK 11195 in corticobasal degeneration (2004) (49)
- Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation (2001) (47)
- Pharmacokinetics of 99Tcm-pertechnetate and 188Re-perrhenate after oral administration of perchlorate: option for subsequent care after the use of liquid 188Re in a balloon catheter. (1998) (47)
- [18F]3'-deoxy-3'-fluorothymidine-PET in NHL patients: whole-body biodistribution and imaging of lymphoma manifestations--a pilot study. (2004) (46)
- Intracoronary &bgr;‐Irradiation With a Rhenium‐188‐Filled Balloon Catheter: A Randomized Trial in Patients With De Novo and Restenotic Lesions (2003) (46)
- Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs. (2000) (46)
- How useful is positron emission tomography for lymphnode staging in non-small-cell lung cancer? (2000) (45)
- Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET (2008) (44)
- Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells (2003) (44)
- Accurate Preoperative Localization of Parathyroid Adenomas With C-11 Methionine PET/CT (2013) (44)
- In vivo assessment of phagocytic properties of Kupffer cells. (1981) (42)
- Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases. (2011) (42)
- Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities. (2002) (42)
- Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. (2012) (41)
- Lymph node staging in lung cancer using [18F]FDG-PET. (2004) (40)
- Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model (2010) (40)
- Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukaemia cells (2003) (39)
- Radiofluorination of PSMA-HBED via Al18F2+ Chelation and Biological Evaluations In Vitro (2015) (39)
- C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. (2010) (39)
- Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? (2000) (38)
- 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging (2003) (38)
- Improved non-invasive T-Staging in non-small cell lung cancer by integrated18F-FDG PET/CT (2007) (38)
- Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia. (2006) (38)
- Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma (2007) (37)
- 123I-phenylpentadecanoic acid as a tracer of cardiac free fatty acid metabolism. Experimental and clinical results. (1985) (37)
- Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells (2003) (37)
- Recent advances in bone marrow scanning (2005) (37)
- Detection of lymph node metastasis in patients with nodal prostate cancer relapse using (18)F/(11)C-choline positron emission tomography/computerized tomography. (2014) (36)
- [Lymph node staging of bladder neck carcinoma with positron emission tomography]. (1999) (35)
- Positron emission tomography for detection and staging of malignant lymphoma. (2000) (33)
- [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions? (2004) (33)
- Assessment of Regional Myocardial Uptake and Metabolism of ω-(p-123I-Phenyl) Pentadecanoic Acid with Serial Single-Photon Emission Tomography (1982) (32)
- Radiosynthesis of a new PSMA targeting ligand ([18F]FPy-DUPA-Pep). (2011) (32)
- CD34+ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients (2004) (32)
- Is 3′-deoxy-3′-18F-fluorothymidine a better marker for tumour response than 18F-fluorodeoxyglucose? (2006) (32)
- Cellular origin and molecular mechanisms of 18F-FDG uptake: is there a contribution of the endothelium? (2004) (31)
- Captopril mediated decrease of aortic regurgitation. (1985) (31)
- Improving Anti-CD45 Antibody Radioimmunotherapy Using a Physiologically Based Pharmacokinetic Model (2009) (31)
- Use of integrated FDG-PET/CT in sarcoidosis. (2008) (30)
- Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep (2014) (30)
- Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D mode. (2004) (29)
- Comment on Afshar-Oromieh et al.: PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions (2013) (29)
- Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET (2001) (28)
- Internal radionuclide therapy: The ULMDOS software for treatment planning. (2005) (27)
- 123I-ITdU–Mediated Nanoirradiation of DNA Efficiently Induces Cell Kill in HL60 Leukemia Cells and in Doxorubicin-, β-, or γ-Radiation–Resistant Cell Lines (2007) (27)
- Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy. (2012) (26)
- False-positive FDG PET in patients with pancreatic masses: an issue of proper patient selection? (1998) (26)
- Cardiac metabolism of omega-(p-iodo-phenyl)-pentadecanoic acid: a gas-liquid chromatographic-mass spectrometric analysis. (1984) (26)
- Comparing time activity curves using the Akaike information criterion (2009) (26)
- Role of whole body FDG-PET imaging in predicting relapse of malignant lymphoma in patients with residual masses after treatment (1999) (25)
- Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors (2010) (24)
- A survey of PET activity in Germany during 1999 (2002) (23)
- Usefulness of FDG-PET in diagnosing primary lymphoma of the liver. (1997) (23)
- Synthesis and evaluation of a radiometal-labeled macrocyclic chelator-derivatised thymidine analog. (2006) (22)
- One pot radiofluorination of a new potential PSMA ligand [Al18F]NOTA‐DUPA‐Pep (2012) (22)
- Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study. (2006) (22)
- Internal radionuclide therapy: the ULMDOS software for treatment planning. (2005) (22)
- Simultaneous iterative reconstruction of emission and attenuation images in positron emission tomography from emission data only. (2002) (22)
- Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma (2007) (22)
- Relation of Myocardial Blood Flow and Initial Cardiac Uptake of 15-(p-123I-Phenyl)-Pentadecanoic Acid in the Canine Heart (1984) (22)
- In vivo evaluation of 5-[(18)F]fluoro-2'-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model. (2001) (21)
- Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation. (2006) (21)
- [18F]FDG-PET in Patients with Alzheimer’s Disease: Marker of Disease Spread (2004) (21)
- Brief S2k guidelines – Merkel cell carcinoma (2013) (21)
- 99Tcm-methoxy-isobutyl-isonitrile SPECT to evaluate a perfusion index from regional myocardial uptake after exercise and at rest. Results of a four hour protocol in patients with coronary heart disease and in controls. (1990) (20)
- [F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes]. (1999) (20)
- F-18 Fluorodeoxyglucose (FDG) and C-Reactive Protein (CRP). (1999) (20)
- Treatment of radioactive decay in pharmacokinetic modeling: influence on parameter estimation in cardiac 13N-PET. (1999) (20)
- Simultaneous iterative reconstruction for emission and attenuation images in positron emission tomography. (2000) (20)
- Physiologically Based Pharmacokinetic Modeling Is Essential in 90Y-Labeled Anti-CD66 Radioimmunotherapy (2015) (20)
- Adenovirus-delivered siRNA. (2004) (20)
- Functional imaging of neuroendocrine tumours with PET (2006) (19)
- 67Ga scintigraphy: procedure guidelines for tumour imaging (2003) (19)
- [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma. (2012) (19)
- New diagnostic imaging procedures in Hodgkin's disease. (1996) (19)
- Reproducibility of a single-sample method for 99Tcm-MAG3 clearance under clinical conditions. (1997) (18)
- Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy. (2003) (18)
- Optimal preloading in radioimmunotherapy with anti-cD45 antibody. (2011) (18)
- Metabolism of 15 (p123I iodophenyl-)pentadecanoic acid in heart muscle and noncardiac tissues (2004) (18)
- Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy. (2012) (18)
- A comparison of the biodistribution and biokinetics of 99mTc-anti-CD66 mAb BW 250/183 and 99mTc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy (2003) (18)
- Triplex forming oligonucleotide targeted to 3'UTR downregulates the expression of the bcl-2 proto-oncogene in HeLa cells. (2001) (17)
- Potential of optimal preloading in anti-CD20 antibody radioimmunotherapy: an investigation based on pharmacokinetic modeling. (2010) (17)
- [Positron emission tomography. Introduction of a new procedure in diagnosis of urologic tumors and initial clinical results]. (1995) (17)
- FDG PET for imaging pericardial manifestations of Hodgkin lymphoma. (2003) (17)
- Endovascular irradiation with the liquid beta-emitter Rhenium-188 to reduce restenosis after experimental wall injury. (2001) (16)
- Intracoronary beta-irradiation with a liquid (188)re-filled balloon: six-month results from a clinical safety and feasibility study. (2000) (15)
- Pro-apoptosis and anti-proliferation effects of a recombinant dominant-negative survivin-T34A in human cancer cells. (2009) (15)
- [Preoperative assessment of asymptomatic adnexal tumors by positron emission tomography and F 18 fluorodeoxyglucose]. (1999) (15)
- New molecular markers for prostate tumor imaging: a study on 2-methylene substituted fatty acids as new AMACR inhibitors. (2011) (15)
- Synthesis and evaluation of 18F-fluoroethylated benzothiazole derivatives for in vivo imaging of amyloid plaques in Alzheimer's disease. (2010) (15)
- [Imaging of the normal skeletal system with 18F Na-PET compared with conventional skeletal scintigraphy using Tc99m-MDP]. (1998) (15)
- [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation. (2003) (14)
- Preferential Tumor Targeting and Selective Tumor Cell Cytotoxicity of 5-[131/125I]Iodo-4′-Thio-2′-Deoxyuridine (2008) (14)
- Fluoro-3-Deoxythymidine ( [ 18 F ]-FLT ) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease (2003) (14)
- Possible site of the in vivo disposition of sodium nitroprusside in the rat (1982) (14)
- [Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty]. (1998) (14)
- Experimental basis of metabolic imaging of the myocardium with radioiodinated aromatic free fatty acids. (1986) (13)
- Labelling of a monoclonal antibody with 68Ga using three DTPA-based bifunctional ligands and their in vitro evaluation for application in radioimmunotherapy (2007) (13)
- Validation of myocardial blood flow estimation with nitrogen-13 ammonia PET by the argon inert gas technique in humans (2001) (13)
- [PET and PET/CT in relapsing prostate carcinoma]. (2006) (13)
- Impact of FDG-PET Computed Tomography for Surgery of Recurrent or Persistent Differentiated Thyroid Carcinoma (2012) (13)
- Reticuloendothelial system Fc-receptor function in patients with immune thrombocytopenia after treatment with high dose intravenous immunoglobulin. (2009) (13)
- Rhenium-188 Labeled Hydroxyapatite and Rhenium-188 Sulfur Colloid (1997) (13)
- Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma (2007) (12)
- Diagnostic accuracy of intraoperative perfusion-weighted MRI and 5-aminolevulinic acid in relation to contrast-enhanced intraoperative MRI and 11C-methionine positron emission tomography in resection of glioblastoma: a prospective study (2018) (12)
- Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i. (2006) (12)
- Lymph node staging for urinary bladder carcinoma with positron emission tomography (PET) (2016) (12)
- Cardiac metabolism of 15 (p-I-123 phenyl-) pentadecanoic acid after intracoronary tracer application. (1984) (12)
- Activation of intrinsic apoptotic pathway by Re-188 irradiation and paclitaxel in coronary artery smooth muscle cells. (2008) (11)
- Internal radionuclide therapy (2006) (11)
- Quantification of 18F-FDG uptake in non-small cell lung cancer: a feasible prognostic marker? (2004) (11)
- Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridine. (2011) (10)
- Novel imaging techniques in NHL: Clinical results with PET imaging (2001) (10)
- Liposomal delivery of antisense oligonucleotides for efficient downregulation of Bcl-2 and induction of apoptosis. (2002) (10)
- Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases. (1993) (10)
- Performance of Integrated FDG-PET/CT for Differentiating Benign and Malignant Lung Lesions - Results from a Large Prospective Clinical Trial (2008) (10)
- Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia. (2008) (10)
- Single photon emission tomography imaging of myocardial oxidative metabolism with 15-(p-[123I]iodophenyl) pentadecanoic acid in patients with coronary artery disease and aorto-coronary bypass graft surgery (2004) (10)
- ROC analysis for assessment of lesion detection performance in 3D PET: influence of reconstruction algorithms. (2003) (9)
- [Reduction of regurgitation in aortic and mitral insufficiency by captopril in acute and long-term trials]. (1985) (9)
- Intracoronary β-brachytherapy using a rhenium-188 filled balloon catheter in restenotic lesions of native coronary arteries and venous bypass grafts (2006) (9)
- Effect of myocardial perfusion and metabolic interventions on cardiac kinetics of phenylpentadecanoic acid (IPPA) I 123 (2004) (9)
- Improving binding potential analysis in [11C]raclopride PET studies using cluster analysis. (2004) (9)
- FDG-PET and PET/CT in malignant lymphoma. (2008) (8)
- Kinetics of 17-(123I) iodoheptadecanoic acid in myocardium of rats (1983) (8)
- Synthesis and Biologic Study of IV-14, a New Ribonucleoside Radiotracer for Tumor Visualization (2009) (8)
- 1011-116 Myocardial Rb Extraction Fraction: Determination in Humans (1995) (8)
- Iterative reconstruction for attenuation correction in positron emission tomography: maximum likelihood for transmission and blank scan. (1999) (8)
- Experimental and clinical experience with iodine 123-labeled iodophenylpentadecanoic acid in cardiology (1994) (8)
- Synthesis and labelling of Df-DUPA-Pep with gallium-68 and zirconium-89 as new PSMA ligands (2014) (8)
- Dosimetrie Fundamentals of Endovascular Brachytherapy Using Re-188 to Prevent Restenosis after Angioplasty (1998) (8)
- Radiosynthesis of [18F]FEt-Tyr-urea-Glu ([18F]FEtTUG) as a new PSMA ligand (2013) (7)
- Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans (2007) (7)
- Patients with in-stent restenoses (2007) (7)
- Reduced technetium 99m labelled NCA-95/CEA-antibody uptake in liver due to gentle antibody reconstitution (2004) (7)
- Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of β-amyloid plaques (2007) (7)
- A 25-year-old woman with a gastric GIST and a PET-positive epicardial tumor (2007) (7)
- Clinical Value of Positron Emission Tomography (PET) in Oncology: Results of an Interdisciplinary Consensus Conference (1996) (7)
- Familial acanthocytosis with paroxysmal exertion-induced dyskinesias and epilepsy (FAPED) (2004) (7)
- Determination of the immunoreactivity of radiolabeled monoclonal antibodies: a theoretical analysis. (2006) (6)
- Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation study. (2011) (6)
- Performance of Integrated FDG-PET/CT for Differentiating Benign and Malignant Lung Lesions -Results from a Large Prospective Clinical Trial (2008) (6)
- Analysing saturable antibody binding based on serum data and pharmacokinetic modelling (2011) (6)
- Synthesis of 15-(4-[131I]iodophenyl)pentadecanoic acid (p-IPPA) via tin-precursor using Chloramine-T as an oxidant (2010) (6)
- [Nuclear imaging of prostate cancer: current status]. (2007) (6)
- [Positron-emission tomography in the diagnosis of abdominal tumors]. (1998) (6)
- Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistribution (2009) (5)
- pore-expanded mesoporous silica nanoparticles for PET (2014) (5)
- [Cause of crossed cerebellar diaschisis in cerebrovascular disease]. (1984) (5)
- Radioiodinated methyl-branched fatty acids: Evaluation of catabolites formed in vivo (1987) (5)
- Elevated FDG uptake in the lactating human breast. (2001) (5)
- [Detection of bone involvement in malignant diseases by immunoscintigraphy of the bone marrow]. (1993) (4)
- Brain Imaging: The Chemistry of Mental Activity (2009) (4)
- Determination of individual organ masses for (90)Y-anti-CD66 radioimmunotherapy: influence on therapy planning. (2011) (4)
- Sustained I-131 phenylpentadecanoic acid (IP) uptake in salvaged myocardium (1984) (4)
- Biodistribution, cellular uptake and DNA-incorporation of the 2'-fluoro stabilized 5-iodo-2'-deoxyuridine analog 5-iodo-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU). (2008) (4)
- [Neurinoma of the recurrent laryngeal nerve--as a case report, an argument for nerve preparation]. (1989) (4)
- Metronomic Treatment with Low-Dose Trofosfamide Leads to a Long-Term Remission in a Patient with Docetaxel-Refractory Advanced Metastatic Prostate Cancer (2010) (4)
- Synthesis of 15-(4-[11C]methylphenyl)pentadecanoic acid (MePPA) via Stille cross-coupling reaction (2011) (4)
- Chromosome instability and tumor lethality suppression in carcinogenesis (2008) (3)
- [For the benefit of the patient: the sentinel node excision]. (2011) (3)
- [Prerequisites for diagnostic use of antisense oligonucleotides in nuclear medicine]. (1996) (3)
- Both total chain length and position of dimethyl-branching effect the myocardial uptake and retention of radioiodinated analogues of 15-(p-iodophenyl)-3,3-dimethylpentadecanoic acid (DMIPP) (1996) (3)
- [Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT]. (1989) (3)
- Pathophysiological Basis and Clinical Value of 18F-Fluorodeoxyglucose and Positron Emission Tomography in Pancreatic Adenocarcinoma (1994) (3)
- Detection of Skeletal Involvement in Malignant Disease by Immunoscintigraphy of Bone Marrow (1993) (3)
- Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation (2009) (3)
- Catabolism of 15-(p-lodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) by isolated rat hearts (2004) (3)
- On the Occurrence of Crossed Cerebellar Diaschisis in Cerebrovascular Disease (1984) (3)
- Prerequisites for the Use of Antisense Oligonucleotides in Nuclear Medicine (1996) (3)
- Cancer Model for Positron Emission Tomography in a Murine Pancreatic-deoxyuridine as Tracer ′ F ] Fluoro-218 Evaluation of 5-[ In Vivo (2001) (3)
- Sodium Nitroprusside: Indication that Peripheral Vascular Beds are the Sites for its Rapid in Vivo Inactivation (1981) (3)
- Production of Zr-89 on a PETtrace cyclotron (2013) (3)
- Myeloablative Radioimmuntherapie mit 188Re-CD66mAb vor Stammzelltransplantation: Kein Anstieg proinflammatorischer Zytokinspiegel von TNF-α (2008) (3)
- Hyperthermia: Different Methods, Different Aims, and Different Problems (1999) (3)
- [Advancement of PET and PET/CT in prostate carcinoma]. (2006) (3)
- Corrigendum to “Delusional infestation: Neural correlates and antipsychotic therapy investigated by multimodal neuroimaging” [Prog. Neuropsychopharmacol. Biol. Psychiatry 34 (2010) 1215–1222] (2012) (3)
- 68Ga-DOTA-DUPA-Pep as a new peptide conjugate for molecular imaging of prostate carcinoma (2011) (3)
- The Bone Scan in Osteomyelosclerosis (2001) (3)
- [Positron emission tomography of the skeletal system using 18FNa: frequency, distribution and appearance of skeletal metastases]. (1999) (3)
- 1019: Clinical Value of [11C] Choline Petict in Patients with Rising PSA After Primary Treatment of Prostate Cancer (2007) (2)
- [Simulation of a mediastinal non-Hodgkin lymphoma recurrence by a diffuse thymus hyperplasia in 18F-FDG PET scan]. (1996) (2)
- Kinetic investigations of the electrophilic N.C.A. radioiodination of 2′‐deoxyuridine using iodogenTM (2001) (2)
- Radiosynthesis of [90Y]DOTA-DUPA-Pep for clinical applications (2014) (2)
- Intracoronary b -Irradiation With a Liquid 188 Re-Filled Balloon Six-Month Results From a Clinical Safety and Feasibility Study (2000) (2)
- Iterative image reconstruction reduces apparent tumor distortion. (1997) (2)
- [Reduction of regurgitation in aortic insufficiency by inhibition of the renin-angiotensin converting enzyme]. (1984) (2)
- Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analogues. (2009) (2)
- Myeloablative radioimmunotherapy with Re-188 labeled anti-CD66-mAB prior to stem cell transplantation of leukemia patients: Correlation of bone marrow dose and engraftment as well as probability of relapse (2001) (2)
- Cardiac metabolism of I-123 phenyl-pentadecanoic acid (1987) (2)
- [Single-photon emission computed tomography (SPECT) of the liver with a rotating gamma camera system (author's transl)]. (1981) (2)
- Positron Emission Tomography with 18-F-Fluorodeoxyglucose in the Staging and Follow-Up of Lymphoma: Status quo and quo vadis (1999) (2)
- Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol. (2004) (2)
- [Positron-emission tomography of the skeletal system using 18FNa: the incidence, pattern of the findings and distribution of benign changes]. (1998) (1)
- Binding affinity and kinetic analyses of modifications of urea-based PCa tracers (2014) (1)
- F-18-FDG-PET for Differential Diagnosis of Pleural Processes (1999) (1)
- Intrathoracic metastatic spread of parathyroid carcinoma (2010) (1)
- Auger-electron-DNA-targeted therapy breaks chemo- and radioresistance in leukemia cells (2007) (1)
- Positron emission tomography (PET): Diagnostic benefit in pancreatic tumors? (1997) (1)
- Viability as seen with radiolabelled fatty acids — a new approach to a challenqinq problem (1994) (1)
- Diagnostic effectiveness, cost-effectiveness and prognostic utility of PET/CT in non-small cell lung cancer (NSCLC) (2008) (1)
- Comparative evaluation of labelling patterns and turnover of lipids, tagged by 15 /p-123I-phenyl-/ pentadecanoic and 1-14C-palmitic acid (1984) (1)
- New solid state target construction on a PETtrace cyclotron (2013) (1)
- Improved Synthesis and in Vitro Stability Test of Rhenium-188 Labeled Radiopharmaceuticals for Potential Use in Radiation Synovectomy (1997) (1)
- [Current status of positron emission tomography in diagnosis of abdominal tumors]. (1999) (1)
- 1816: 11C-Cholin-Pet/Ct a new Image Modality in Prostate Cancer Detection (2004) (1)
- Heterozygous R1101K mutation of the DCTN1 gene in a family with amyotrophic lateral sclerosis and frontotemporal dementia (2005) (1)
- Radioimmunotherapy for Myeloablation Before SCT in Paediatric Patients with Malignant and Non-Malignant Diseases. (2007) (1)
- Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation (2000) (1)
- Captopril-induced reduction of regurgitation fraction in aortic insufficiency: Acute and long-term effects (1985) (1)
- PET Assessment of Lymphoma: Beyond (18)F-Fluorodeoxyglucose. (2006) (1)
- [18F]Dihydroxyphenylalanine-PET/CT in pheochromozytoma (2007) (1)
- Assessment and Quantification of Regional Arterial Perfusion Reserve in Patients with Peripheral Occlusive and Small-Vessel Disease by Rubidium 82-Positron Emission Tomography (1996) (1)
- Indikationen der modernen PET/CT-Diagnostik (2013) (1)
- [The noninvasive determination of resting myocardial blood flow in patients using 82 Rb in comparison with the argon method]. (1993) (1)
- Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLT. (2007) (1)
- Detection of local recurrence by means of 11-C-Choline-PET/CT after radical prostatectomy for conformal radiation therapy (2003) (1)
- Radiosynthesis of carbon-11 labeled 6-methyldopamine ([¹¹C]MeDA). (2012) (1)
- Mono- and dimethylbenzyls as new protecting groups for no-carrier-added nucleophilic aromatic radiofluorination (2011) (1)
- 1011-117 Comparison of 82Rubidium Positron Emission Tomography to 99Technetium-Methoxyisobutyl Isonitrile Perfusion Imaging (1995) (1)
- 856 11C-Choline-PET/CT determines potentially curative patients with prostate cancer recurrencies (2003) (1)
- 259Lymph node staging in prostate cancer by the use of 11C-choline-PET/CT scan imaging (2005) (1)
- Radioimmunotherapy with Re-188 labelled anti-CD66 antibody for myeloablation prior to stem cell transplantation in high risk leukemia patients (2000) (0)
- [Results of fatty acid SPECT of the myocardium in coronary disease]. (1986) (0)
- Auger-electron-emitter labelled triplex forming oligonucleotides form stable triple helices and inhibit transcription in vitro (2001) (0)
- Elevated Expression of Glucose Transporter Genes as Reason for an Increased F-18 FDG Uptake in Human Pancreatic Adenocarcinoma (1997) (0)
- Localization of residual disease in medullary thyroid carcinoma by integrated 18F-DOPA PET / CT (2006) (0)
- Coronary Artery Disease (CAD): ROC-Analysis of Tc-99m-MIBI-SPECT Versus Rb-82-PET (1997) (0)
- 10-9 Total sleep deprivation and cerebral glucose utilization in depression (1997) (0)
- Uptake and metabolism of N-13-ammonia in SCID mouse xenografts (2011) (0)
- 855 Detection of local recurrence by means of 11C-Choline-PET/CT after radical prostatectomy for conformal radiation therapy (2003) (0)
- [The importance of PET in searching the primary tumor site in CUP patients -- a case report]. (2005) (0)
- Radioresistance to yttrium-90 and gamma-irradiation depends on DNA-double-strand-break repair (2007) (0)
- Non-Invasive Detection of Resting Myocardial Blood Flow with 82Rb PET in Patients Compared to the Argon Method (1993) (0)
- TABLE 1 Number of Patients with FDG PET and Bone Scintigraphy in 56 (2006) (0)
- Dosimetry with 188Re-labelled monoclonal anti-CD66 antibodies (2006) (0)
- An attractive approach for HPLC detection of both β+/β- emitters (2011) (0)
- 854 Postoperative dilemma of rising PSA levels in patients with prostatectomy: Evaluation of 11C-Choline-PET/CT examination for radiation therapy (2003) (0)
- Synthesis and biological evaluation of the new radioiodinated pyrimidine nucleosides (2007) (0)
- Turnover of lipids labeled by I-123 phenylpentadecanoic acid (IP) compared to C-14 palmitic acid (P) (1984) (0)
- In vivo amyloid imaging with the new radiotracer [N-Methyl-11C]2-(4'-(methylamino)phenyl)-benzothiazol (C-11-BTA-1) in Alzheimer's disease (2006) (0)
- Differences in predicted and actually absorbed doses in sst2 targeting peptide therapy (2012) (0)
- Preparation of 15-(4-[11C]methylphenyl)pentadecanoic acid (MePPA) as a new tracer for studies in animal models (2011) (0)
- Antigene effects of bcl-2 targeting triple helix-forming oligonucleotides in human lymphoma cells (2001) (0)
- Synthesis of no-carrier-added 6-[11C]methyl-l-DOPA (2012) (0)
- Physiologically based pharmacokinetic (PBPK) model for CD45-antibody radioimmunotherapy (RIT) with preloading (2008) (0)
- Reliable Diagnosis of Pancreatic Adenocarcinoma with 18-F-2-FDG-Positron-Emission-Tomography (PET) (1995) (0)
- FDG-PET in staging primary gastrointestinal lymphoma (1998) (0)
- Prediction of axillary lymphatic node status in primary breast cancer — Comparison between positron emission tomography (PET) and sentinel-node biopsy (1998) (0)
- [Vasodilating-acting antihypertensive agents: model substance sodium nitroprusside]. (1977) (0)
- 31st Annual Meeting of the German Association of Endocrine Surgeons (CAEK) (2012) (0)
- Kinetics of Radioiodinated Isopropylamphetamine in Blood and Brain (1985) (0)
- Radioiodinated fenetylline (captagon): A new potential brain imaging agent (1984) (0)
- PET in Abdominal Imaging of Tumors and Infections (1999) (0)
- European Association of Nuclear Medicine Congress 10–14 October 1993, Lausanne, Switzerland (2004) (0)
- Synthesis, radiolabeling and biological evaluation of new iodo-vinyl-pyrimidine nucleosides (2007) (0)
- Efficient radiosynthesis of a new PSMA ligand: [Al18F]DTPA-CHX-DUPA-Pep (2014) (0)
- PET/CT for restaging breast cancer - Impact on patient management and patient outcome (2008) (0)
- Accurate diagnosis of pancreatic carcinoma with positron-emission-tomo-graphy (PET) and fluoro-18-2-deoxy-D-glucose (FDG) (1996) (0)
- Bestimmung der regionalen Herzmuskelaufnahme und des Stoffwechsels von oo-mJ-Paraphenylpentadecansäure mittels der sequentiellen Single-Photon-Emissionstomographie (1982) (0)
- SPECT of the Brain Using Radiolabeled Amphetamines and a Rotating Gamma Camera (1985) (0)
- Determination of the Myocardial Rubidium Extraction Fraction: Theoretical Investigation (1997) (0)
- FDG-PET and PET/CT in Pancreatic Cancer (2008) (0)
- Synthesis and preclinical study of IV-14 - New radioiodinated ribonucleoside (2008) (0)
- [11C]Methylation of dopamine as a new tracer for preclinical studies (2011) (0)
- Synthesis of no-carrier-added 6-[C-11]methyl-L-DOPA (2012) (0)
- One pot radiosynthesis of a new PSMA ligand [Al18F]NOTA-DUPA-Pep (2012) (0)
- Preoperative Thoracic Staging of Non-Small Cell Lung Cancer: 18-FDG-PET Evaluation (1997) (0)
- Monte Carlo Modeling of the Effects of Cascade Gamma Photons in 2D PET Images Obtained With the Isotopes: Br (2009) (0)
- A new ribonucleoside radiotracer for tumor visualization and radiotherapy: Synthesis and biological study (2009) (0)
- The Metabolism of Radioiodinated Free Fatty Acids in the Heart. Physiological Basis and Cardiac Biokinetics (1985) (0)
- Inhibition of cell cycle progression and induction of apoptosis in a human lung carcinoma cell line mediated by survivin-specific triplex forming oligonucleotides (2002) (0)
- Model selection and parameter inference for sparse pharmacokinetic data: Efficacy of the Akaike Information Criterion (AICc) and the F-test (2008) (0)
- [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow]. (1990) (0)
- Zr-89 labeling of mesoporic silica based nanoparticles (2014) (0)
- Intensification of the Conditioning Regimen for Patients with high-risk AML and MDS: 3 year Experience of using an188 Re — Labelled anti — CD 66 Monoclonal Antibody (2003) (0)
- 95 New PET-Tracers for imaging pathophysiology and response (2009) (0)
- Radioimmunotherapy (RIT) with anti-CD45 antibody: Optimal timing of the preload (2009) (0)
- 264C-11 choline-PET/CT in primary localised prostate cancer: A comparison of a non-invasive method vs. surgery (2005) (0)
- Optimizing radioimmunotherapy with anti-CD66 antibody using physiologically based pharmacokinetic (PBPK) modeling (2009) (0)
- [Significance of PET for ENT-tumors]. (2004) (0)
- Artifacts in Reconstructed PET-Images Due to Variation in Detector Sensitivity (1997) (0)
- Radiofluorination and docking studies for [18F]FEt-Tyr-urea-Glu ([18F]FEt-TUG) as a new potential PSMA ligand (2013) (0)
- [SPECT (201T1) of the myocardium after experimental infarction]. (1982) (0)
- Tc-99m-Sestamibi Whole-Body Distribution after Stress Testing with Arbutamine and Dipyridamole: a Comparison with Resting Condition (1997) (0)
- 1596: Lymph Node Staging in Prostate Cancer by the use of 11C-CHOLIN-PET/CT Scan Imaging (2005) (0)
- Imaging of prostate carcinoma using PSMA-addressing peptide conjugates (2012) (0)
- – Prostate Cancer New Clinical Indications for 18 F / 11 C-choline , New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging : A Systematic Review of the Literature (2016) (0)
- 1531: Visualisation of Local Recurrence after Definite Prostate Cancer Treatment by the use of 11C-CHOLIN-PET/CT (2005) (0)
- Noninvasive Determination of the Arterial Input Function: General Description for an Artery Surrounded by Homogeneous Tissue (1995) (0)
- Overcoming chemoresistance and radioresistance in leukemia cells using Bi-213 labeled anti-CD45 monoclonal antibody (2006) (0)
- Phonological and visuospatial working memory: A common network and sources of lateralization (2001) (0)
- [18F]-Labeling in substituted 2-nitropyridine as a surrogate for benzene in radiopharmaceuticals (2011) (0)
- Preferential tumor targeting and selective cytotoxicity of 5-[131/125I]-iodo-4'-thio-2'-deoxyuridine (2008) (0)
- Internal radionuclide treatment planning using tomographic data: The extended ULMDOS software (2006) (0)
- Efficient labeling procedure for triplex forming oligonucleotides with the Tc-99m-tricarbonyl-complex (2002) (0)
- Radiolabeled DNase, a potential indicator for noninvasive detection of tissue damage (2004) (0)
- Modeling Radioimmunotherapy with Anti-CD20 Antibody – Optimal Preload Depending on Lymphoma Transcapillary Solute Exchange (2009) (0)
- COMBINED 11C-CHOLINE POSITRON EMISSION TOMOGRAPHY/ COMPUTER TOMOGRAPHY (11C-CHOLINE PET/CT) FOR THE EVALUATION AFTER HIGH INTENSITY ULTRASOUND (HIFU) TREATMENT IN LOCALISED PROSTATE CANCER (2008) (0)
- Synthesis of the new tracer L-6-[11C]methyl-DOPA (2011) (0)
- Analysis of the molecular pathways of Bi-213 bound to anti-CD45-induced cell death in comparison to the molecular pathways of Y-90 bound to anti-CD45-induced cell death (2007) (0)
- PET Imaging of Breast Cancer Molecular Biomarkers (2008) (0)
- 15(p-['231]Iodophenyl)Penadecanoic Acid as Tracer of Lipid Metabolism: Comparisonwith [1-'4C]PalmiticAcid in MurineTissues (2006) (0)
- Viability as seen with radiolabelled fatty acids — a new approach to a challenqinq problem (2004) (0)
- Synthesis and labeling of CHX-A''-DTPA-DUPA-Pep with gallium-68, zirconium-89 and lutetium-177 for diagnosis and therapy of prostate cancer (2014) (0)
- Integrated 11C-methionine PET / CT to detect occult residual parathyroid cancer (2006) (0)
- Comparison of parametric contrast enhanced ultrasound (SonoVue®) with quantified F-18-FDG-PET-CT in determining the vitality of liver lesions by hepatic alveolar echinococcosis (2013) (0)
- [18F]FPy-DUPA-Pep as a new ligand for PSMA-specific imaging of prostate cancer (2011) (0)
- [Localization of pre-excitation in the WPW syndrome by analysis of the ventricular contraction course]. (1985) (0)
- Myeloablative radioimmunotherapy: Comparison of biodistribution and biokinetics of Tc-99-anti-CD66-mAb vs. Tc-99-anti-CD45-mAb (2001) (0)
- Comparison of kinetics between I-123-heptadecanoic acid (IHDA), I-125-phenylpentadecanoicacid (IPPA) and I-131-dimethylphenylpentadecanoic acid (DMIPPA), in the normal dog heart (1987) (0)
- Physiologically based pharmacokinetic modeling: Investigating bivalent antibody-antigen interaction (2009) (0)
- Cardiac radionuclide imaging. (1989) (0)
- Cost-effectiveness of anatometabolic imaging with PET/CT for staging of NSCLC (2009) (0)
- Comparison of the blood serum biokinetics of In-111 and Y-90 labelled antibodies using an information theoretic approach (2007) (0)
- Is there a role for dose painting within the prostate in the primal therapy of patients with localized prostate cancer using choline PET/CT, dynamic MRI and CAD or choline MRS? (2010) (0)
- 67 poster: 18F-FDG PET/CT as a Selection Tool for Image Guided Radiotherapy (IGRT) in Patients with Recurrent or Residual Ovarian Cancer (2010) (0)
- Synthesis and labeling of DOTA-SOM230 conjugates (2007) (0)
- [Whole body distribution of Tc-99m-sestamibi after pharmacological stress with arbutamine and dipyridamole compared with resting conditions]. (1997) (0)
- Therapy for Patients with Rectal Carcinoma (1999) (0)
- In comparison to F18-sodium fluoride PET the extent of metastatic bone disease is underestimated with FDG in lung cancer patients (2007) (0)
- 2-Methylen substituted fatty acids (2-MFAs) as potential AMACR-specific tracers. Synthesis and in vitro study (2010) (0)
- 1957: Visualisation of Rising PSA after RPX by the Use of 11C-Cholin-PET/CT (2004) (0)
- [PET in pancreatic tumor of unknown origin--luxury or value?]. (1997) (0)
- Diagnosis — Methods for Evaluating Myocardial Microcirculation in Patients (1982) (0)
- Investigating the relevance of saturable binding in radioimmunotherapy using pharmacokinetic modeling (2010) (0)
- Evaluation of mRNA Targeting by Labeled Oligonucleotides for Tumor-Diagnosis (1999) (0)
- Evaluation of f-18-fdg pet/ct in patients suspected of local recurrence of colorectal cancer introduced to external conformal radiotherapy (2004) (0)
- A Method for Determination of Regional Myocardial Blood Flow (RMBF) Considering Regional Spillover (1995) (0)
- An attractive approach for HPLC detection of both {beta}+/{beta}- emitters (2011) (0)
- Increased renal toxic effect of total body irradiation in combination with radioimmunotherapy (2001) (0)
- [Experimental myocardial infarct in computerized tomography]. (1982) (0)
- 54 poster: Is there a Role for dose Painting within the Prostate in the Primal Therapy of Patients with Localized Prostate Cancer using Choline PET/CT, Dynamic MRI and CAD or Choline MRS? (2010) (0)
- S2073 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHIC IMAGING OF INFLAMMATORY DISEASE AFTER TOTAL KNEE REPLACEMENT (2004) (0)
- Early D etection a nd A ccurate D escription o f E xtent o f Metastatic B one D isease i n B reast C ancer W ith F luoride Ion a nd P ositron E mission T omography (1999) (0)
- Structural and functional abnormalities of the brain in myotonic dystrophy type 1 (MD1) and 2 (MD2) (2008) (0)
- Molecular imaging of leukemia with FLT-PET (2007) (0)
- In vivo studies of a 5-[I-131/125]-iodo-4'-thio-2'-deoxyuridine in a HL60-xenograft mouse model: Effects of the thymidylate synthase inhibitor 5-fluoro-2'-deoxyuridine (2007) (0)
- Subject Index Vol. 11, 1994 (1994) (0)
- Diagnosis ofpancreatic cancer by 2(18F) -fluoro-2-deoxy- D-glucose emission tomography (1995) (0)
- Polytrauma-CT – Goldstandard ohne Standard? (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Sven Norbert Reske?
Sven Norbert Reske is affiliated with the following schools: